Thu, November 10, 2022
Wed, November 9, 2022
Tue, November 8, 2022
Mon, November 7, 2022

Andrew Fein Maintained (UBX) at Strong Buy with Decreased Target to $10 on, Nov 9th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-10-on-nov-9th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Decreased Target from $12 to $10 on, Nov 9th, 2022.

Andrew has made no other calls on UBX in the last 4 months.



There are 3 other peers that have a rating on UBX. Out of the 3 peers that are also analyzing UBX, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $36 on, Wednesday, November 2nd, 2022
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Tuesday, August 16th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $80 on, Monday, August 15th, 2022

Publication Contributing Sources